Development and Testing of a Peer-Coaching Model for the Treatment of Eating Disorders
Launched by ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · Sep 28, 2022
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
A total of 70 adolescents with eating disorders between the ages of 12-18 and their parents/caregivers will be enrolled in a randomized-controlled trial comparing parent coaching/patient education to parent education/patient coaching. Measures will include demographics, vitals, parent and patient self-efficacy, quality of life, illness related distress/impairment, and changes in eating disorder symptoms and severity.
During a screening and consenting visit, participants will complete assessments including height, weight, demographics, and interview questions to determine inclusion/exclusio...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ages 12 to 18 at entry to the study
- • DSM-5 Diagnosis of an eating disorder
- • Enrollment in treatment at the Center of Excellence for Eating and Weight Disorders Speak English
- • Have access to a phone with WiFi or a data plan
- • Parent and child/patient both willing to participate
- Exclusion Criteria:
- • Current or lifetime history of learning disorder or developmental disorder
- • Acute suicide risk
About Icahn School Of Medicine At Mount Sinai
The Icahn School of Medicine at Mount Sinai is a premier academic institution located in New York City, renowned for its commitment to advancing medical research, education, and patient care. As a leading sponsor of clinical trials, the institution leverages its state-of-the-art facilities and multidisciplinary expertise to drive innovative research initiatives aimed at improving health outcomes. With a focus on translational medicine, the Icahn School of Medicine collaborates with a diverse network of researchers, clinicians, and industry partners to explore novel therapies and interventions across a wide range of medical disciplines. Its rigorous scientific approach and dedication to ethical standards position it as a trusted leader in the clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Tom Hildebrandt, PsyD
Principal Investigator
Icahn School of Medicine at Mount Sinai
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials